Casana is shaking up the healthcare industry with its smart toilet seat technology, the Heart Seat®. This innovative device, which is FDA-cleared, offers a seamless solution for in-home health monitoring by capturing heart rate and blood oxygenation. The company, founded in 2018 and based in the United States, is redefining the future of healthcare delivery. With its recent $40.00M Series B investment from prominent backers such as General Catalyst, Outsiders Fund, Matrix, and Morningside Venture Investments on 21 January 2022, Casana is set to make a significant impact. The company's slogan, "Meet the future of in-home health monitoring, where you’d least expect it," encapsulates its mission to introduce transformative healthcare solutions in unexpected places. The promise of making the Heart Seat commercially available pending the clearance of non-invasive blood pressure further underscores Casana's commitment to revolutionizing in-home health monitoring.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Series B | $40.00M | 4 | Morningside Venture Investments | 21 Jan 2022 |
Series A | $14.00M | 3 | Bemis Manufacturing | 03 Feb 2021 |
Series A | $30.00K | 1 | Launch NY | 13 Aug 2020 |
Seed Round | $2.20M | 6 | RIT Venture Fund I, LLC, Launch NY +1 | 01 Apr 2020 |
Angel Round | Unknown | 1 | 01 Dec 2019 |
No recent news or press coverage available for Casana.